Daejin Kim Selected Research

Daejin Kim Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 11/2003
11	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2010
9	Colonic Neoplasms (Colon Cancer) 10/2020 - 07/2016
8	Melanoma (Melanoma, Malignant) 03/2022 - 11/2003
8	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2013
4	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 11/2016
4	Epstein-Barr Virus Infections 12/2015 - 05/2011
4	Breast Neoplasms (Breast Cancer) 04/2015 - 12/2009
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2014 - 01/2008
3	Infections 12/2017 - 01/2008
3	Lymphoma (Lymphomas) 08/2014 - 09/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 07/2016
2	Carcinogenesis 01/2019 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
2	Carcinoma (Carcinomatosis) 02/2018 - 03/2010
2	Inflammation (Inflammations) 02/2018 - 05/2015
2	Multiple Myeloma 05/2017 - 12/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2015 - 09/2004
2	Stomach Neoplasms (Stomach Cancer) 04/2015 - 02/2013
2	Communicable Diseases (Infectious Diseases) 09/2012 - 07/2007
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2009 - 12/2008
1	Dementia (Dementias) 10/2023
1	Short Bowel Syndrome 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Obesity 01/2021
1	Anemia 01/2020
1	Acne Vulgaris 01/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
7	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2009
7	Therapeutic UsesIBA 01/2021 - 11/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 09/2004
7	AntigensIBA 08/2014 - 07/2007
6	VaccinesIBA 08/2014 - 01/2008
5	EnzymesIBA 03/2022 - 09/2012
5	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 07/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 03/2014
5	Peptides (Polypeptides)IBA 11/2017 - 03/2014
5	Interleukin-18 (Interleukin 18)IBA 11/2016 - 12/2003
5	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2012 - 11/2003
5	DNA VaccinesIBA 10/2010 - 11/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 07/2016
4	Celecoxib (Celebrex)FDA Link 10/2018 - 05/2014
4	Bortezomib (Velcade)FDA Link 10/2018 - 05/2013
4	Protein Isoforms (Isoforms)IBA 02/2018 - 10/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 11/2003
4	Phosphotransferases (Kinase)IBA 08/2017 - 03/2014
4	CytokinesIBA 01/2017 - 05/2015
4	DNA (Deoxyribonucleic Acid)IBA 05/2008 - 11/2007
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 11/2016
3	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 07/2016
3	idelalisibIBA 02/2018 - 05/2015
3	Fibronectins (Fibronectin)IBA 11/2017 - 07/2009
3	Cadherins (E-Cadherin)IBA 11/2016 - 02/2013
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2003
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 08/2017
2	LigandsIBA 01/2020 - 03/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 11/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	CollagenIBA 01/2020 - 11/2016
2	multidrug resistance-associated protein 1IBA 07/2019 - 05/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019 - 07/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2018 - 07/2008
2	Retinal Pigments (Pigments, Visual)IBA 01/2018 - 01/2016
2	Protein Kinases (Protein Kinase)IBA 12/2017 - 08/2017
2	ampelopsinIBA 12/2017 - 01/2017
2	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 12/2017 - 07/2016
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 12/2017 - 03/2011
2	Acetylcysteine (Siran)FDA LinkGeneric 12/2017 - 11/2003
2	Melphalan (Alkeran)FDA LinkGeneric 11/2017 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2004
2	Sorafenib (BAY 43-9006)FDA Link 08/2017 - 03/2014
2	Galectin 1 (LGALS1)IBA 05/2017 - 01/2017
2	Docetaxel (Taxotere)FDA Link 02/2017 - 03/2014
2	Toll-Like Receptor 4IBA 01/2017 - 07/2016
2	LipopolysaccharidesIBA 11/2016 - 07/2016
2	InterleukinsIBA 10/2016 - 05/2015
2	Glycogen Synthase KinasesIBA 07/2016 - 12/2006
2	SurvivinIBA 07/2016 - 04/2014
2	X-Linked Inhibitor of Apoptosis ProteinIBA 07/2016 - 12/2013
2	GoldIBA 08/2014 - 08/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 05/2008
2	LuciferasesIBA 07/2010 - 07/2007
1	Glucagon (Glukagon)FDA Link 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	QuinazolinesIBA 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	TropomyosinIBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2020
1	Erythropoietin FDA Link 01/2020

Therapy/Procedure

12	Therapeutics 01/2020 - 11/2009
9	Drug Therapy (Chemotherapy) 10/2020 - 09/2004
5	Immunotherapy 08/2014 - 05/2008
2	Aftercare (After-Treatment) 02/2017 - 07/2016
1	Long-Term Care 10/2023